Mercks

Dr Reddy's Launches Generic Version Of Mercks Proscar Tablets

Pharma major Dr Reddy's Laboratories today announced that it has launched the authorized generic version of Merck's Proscar tablets 5 mg (Finasteride) on June 19. // The company has also launched the authorized generic version of Merck's Zocor tablets (Simvastatin) 5 mg, 10 mg, 20 mg, 40 mg a...

Old dogs: Prior knowledge affects how consumers accept new information

...d predicted creaminess. This research has important implications for marketers, policy makers and consumers. For instance, the researchers point to mercks introduction of the cholesterol-lowering drug Simvastatin under the brand name Zocor. Recently, researchers found that Simvastatin may be also effecti...

FDA petition would protect public from dangerous drugs

...entered methods. Recent pharmaceutical product testing failures include mercks HIV vaccine, which appeared safe and effective when tested in monkeys. Subsequently, a large international clinical trial was halted when mercks new vaccine appeared to increase the risk that a human patient would contra...

Mercks in Biological Technology

Chipping Away at Drug Development

...product?" "Market research reports only go so far," he said. Fortunately, Vodenlich and his fellow officers at GenTel have the warm contacts at the mercks and Pfizers of the world to move beyond cold calls and into market research meetings to test-drive their ideas. Plus, they have a leader with enough m...

The greatest life-science developments of 2004

...act will these have on the future? While a lot of things have happened in 2004 in the land of biotech and pharmaceuticals, the answer could be: 1. mercks taking Vioxx off the market due to potent cardiovascular side effects and the resultant scrutiny on the FDA for not being on top of a companys drug re...

Line between big pharma, big biotech continues to blur

...et valuation of the top 10 Big Pharma companies over the course of 2004. Lets take a look at their findings: The vertiginous drop in Pfizer and mercks market valuation has been the subject of a prior column and can mostly be attributed to the market withdrawal of their respective Cox-2 inhibitors. Ev...

The 3 percent solution: Unpopular drug companies still push discovery

...d have been much closer to correct. People love to hate drug companies. Politicians know that, and they rarely miss a chance to hammer the Pfizers, mercks and Abbots of the world for running too many expensive television ads, for charging too much for their products, and for generally engaging in some so...